Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3323 ARTÍCULOS , VIENDO DEL 2146 AL 2160

Altered tryptophan metabolism in Parkinson's disease: a possible novel therapeutic approach

Szabó N, Kincses ZT, Toldi J, Vécsei L.

J Neurol Sci. 2011 Nov 15;310(1-2):256-60. doi: 10.1016/j.jns.2011.07.021. Epub 2011 Aug 6.

A randomized pilot trial of estrogen replacement therapy in post-menopausal women with Parkinson's disease

Parkinson Study Group POETRY Investigators.

Parkinsonism Relat Disord. 2011 Dec;17(10):757-60. doi: 10.1016/j.parkreldis.2011.07.007. Epub 2011 Aug 6.

Once-weekly risedronate for prevention of hip fracture in women with Parkinson's disease: a randomised controlled trial

Sato Y, Iwamoto J, Honda Y.

J Neurol Neurosurg Psychiatry. 2011 Dec;82(12):1390-3. doi: 10.1136/jnnp.2011.244574. Epub 2011 Aug 8.

Caring for bladder dysfunctions in patients with Parkinson's disease

Bolgeo T.

Arch Ital Urol Androl. 2011 Jun;83(2):112-5.

Altered glycogen metabolism in cultured astrocytes from mice with chronic glutathione deficit; relevance for neuroenergetics in schizophrenia

Lavoie S, Allaman I, Petit JM, Do KQ, Magistretti PJ.

PLoS One. 2011;6(7):e22875. doi: 10.1371/journal.pone.0022875. Epub 2011 Jul 28.

Disease severity and progression in progressive supranuclear palsy and multiple system atrophy: validation of the NNIPPS--Parkinson Plus Scale

Payan CA, Viallet F, Landwehrmeyer BG, Bonnet AM, Borg M, Durif F, Lacomblez L, Bloch F, Verny M, Fermanian J, Agid Y, Ludolph AC, Leigh PN, Bensimon G; NNIPPS Study Group.

PLoS One. 2011;6(8):e22293. doi: 10.1371/journal.pone.0022293. Epub 2011 Aug 4.

[Violence in the caregiver-patient dyad in Parkinson disease: 3 measurement methods]

Sánchez-Guzmán MA, Paz-Rodríguez F.

Salud Publica Mex. 2011 May-Jun;53(3):203-4.

Brain perfusion differences in parkinsonian disorders

Kimura N, Hanaki S, Masuda T, Hanaoka T, Hazama Y, Okazaki T, Arakawa R, Kumamoto T.

Mov Disord. 2011 Dec;26(14):2530-7. doi: 10.1002/mds.23915. Epub 2011 Aug 9.

Blood-brain barrier P-glycoprotein function in neurodegenerative disease

Bartels AL.

Curr Pharm Des. 2011;17(26):2771-7. doi: 10.2174/138161211797440122.

Overnight switch from ropinirole to transdermal rotigotine patch in patients with Parkinson disease

Kim HJ, Jeon BS, Lee WY, Lee MC, Kim JW, Kim JM, Ahn TB, Cho J, Chung SJ, Grieger F, Whitesides J, Boroojerdi B.

BMC Neurol. 2011 Aug 10;11:100. doi: 10.1186/1471-2377-11-100.

Imaging correlates of apathy and depression in Parkinson's disease

Benoit M, Robert PH.

J Neurol Sci. 2011 Nov 15;310(1-2):58-60. doi: 10.1016/j.jns.2011.07.006. Epub 2011 Aug 9.

The enigma of the E326K mutation in acid β-glucocerebrosidase

Horowitz M, Pasmanik-Chor M, Ron I, Kolodny EH.

Mol Genet Metab. 2011 Sep-Oct;104(1-2):35-8. doi: 10.1016/j.ymgme.2011.07.002. Epub 2011 Jul 12.

Do neurologists make a difference in Parkinson disease care?

Burke JF, Albin RL.

Neurology. 2011 Aug 30;77(9):814-5. doi: 10.1212/WNL.0b013e31822b0118. Epub 2011 Aug 10.

Neurologist care in Parkinson disease: a utilization, outcomes, and survival study

Willis AW, Schootman M, Evanoff BA, Perlmutter JS, Racette BA.

Neurology. 2011 Aug 30;77(9):851-7. doi: 10.1212/WNL.0b013e31822c9123. Epub 2011 Aug 10.

Associated factors for REM sleep behavior disorder in Parkinson disease

Sixel-Döring F, Trautmann E, Mollenhauer B, Trenkwalder C.

Neurology. 2011 Sep 13;77(11):1048-54. doi: 10.1212/WNL.0b013e31822e560e. Epub 2011 Aug 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias